|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/28 | |||
| A61K 9/26 | |||
| A61K 33/06 |
| (11) | Number of the document | 2305282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10182575.0 |
| Date of filing the European patent application | 1998-11-30 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 67740 P | 1997-12-02 | US | |
| 80970 P | 1998-04-07 | US |
| (72) |
Schenk, Dale B., US
|
| (73) |
Janssen Alzheimer Immunotherapy,
Airton Road Tallaght, Dublin 24,
IE
|
| (54) | Prevention and treatment of amyloidogenic disease |
| Prevention and treatment of amyloidogenic disease |